Merck prevails in US safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
Federal Judge Rules in Merck’s Favor in Gardasil Safety Suit
A federal judge ruled in Merck & Co.’s favor in a safety lawsuit over its Gardasil vaccine, allowing the drugmaker to ...
Merck prevails in Gardasil safety litigation
A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a ...
Fierce Pharma3d
Merck defeats claims it should have added safety warnings to Gardasil's label, knocking out 200-plus lawsuits
In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...
BioSpace4d
Good Day for Gardasil as Merck Wins Safety Suit, Drops $1B for Manufacturing Push
According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...
Gardasil maker completes $1B North Carolina expansion — more growth on the way
New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A ...
Merck scores victory in Gardasil lawsuits as judge questions evidence
Federal judge rules in favor of Merck over Gardasil lawsuits, citing lack of evidence linking the HPV vaccine to serious ...
Union Leader4d
Merck prevails in safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
Reuters5d
Merck prevails in US safety litigation over Gardasil HPV vaccine
March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...
Merck completes $1B North Carolina expansion — more growth on the way
Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors To Secure Counsel Before Important Deadline In Securities Class Action MRK
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the“Class ...